Ontology highlight
ABSTRACT: Introduction
A growing number of studies have explored the association between the pretreatment lymphocyte-to-monocyte ratio (LMR) and survival outcomes in various cancers. However, its prognostic significance on bladder cancer remains inconsistent. The aim of this meta-analysis was to evaluate the prognostic value of pretreatment LMR in bladder cancer.Methods
The MEDLINE, EMBASE, Cochrane Library, and CNKI databases were comprehensively searched for relevant studies. A meta-analysis of overall survival (OS), recurrence-free survival (RFS), or cancer-specific survival (CSS) clinicopathological features was conducted.Results
Nine studies containing 5,638 cancer patients were analyzed in this meta-analysis. Patients with high LMR tended to have favourable OS (HR: 0.63, 95% CI: 0.50-0.80, P < 0.001), RFS (HR: 0.59, 95% CI: 0.38-0.91, P = 0.017), and CSS (HR: 0.76, 95% CI: 0.70-0.83, P < 0.001). Moreover, low LMR was highly correlated with age (?60), differentiation (low), T stage (III-IV), lymph node metastasis (yes), and concomitant Cis (yes).Conclusion
Pretreatment LMR might be a useful predictor of survival outcomes in patients with bladder cancer.
SUBMITTER: Ma JY
PROVIDER: S-EPMC6476040 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Ma Jian-Ying JY Hu Gang G Liu Qin Q
Disease markers 20190404
<h4>Introduction</h4>A growing number of studies have explored the association between the pretreatment lymphocyte-to-monocyte ratio (LMR) and survival outcomes in various cancers. However, its prognostic significance on bladder cancer remains inconsistent. The aim of this meta-analysis was to evaluate the prognostic value of pretreatment LMR in bladder cancer.<h4>Methods</h4>The MEDLINE, EMBASE, Cochrane Library, and CNKI databases were comprehensively searched for relevant studies. A meta-anal ...[more]